Clinical trials referenced in this document:
Documents that mention this clinical trial
Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
Funding for this research was provided by:
Wellcome Trust (101148/Z/13/Z)
Bill and Melinda Gates Foundation (OPP1081420)
Received: 19 June 2019
Accepted: 8 December 2019
First Online: 18 December 2019
Ethics approval and consent to participate
: The studies were approved by the Cambodian National Ethics Committee for Health Research (0029NECHR, dated04Mar2013), the Institute of Malariology, Parasitology, and Entomology in Ho Chi Minh City (185/HDDD, dated 15May2013), the Institute of Malariology, Parasitology, and Entomology in Quy Nhon (dated 14Oct2013), the Lao National Ethics Committee for Health Research (RefNo0132015/NECHR), the Government of the Lao PDR, and the Oxford Tropical Research Ethics Committee (1015–13, dated29Apr2013). Each participant, or parent/guardian in the case of minors, provided individual, signed, informed consent; illiterate participants provided a fingerprint countersigned by a literate witness (ClinicalTrials.govIdentifier:NCT01872702).
: Not applicable.
: The authors declare that they have no competing interests.